The role of atrial fibrillation (AF) ablation in the management of heart failure with preserved ejection fraction (HFpEF) remains an under investigated issue with no robust clinical trials data. This controversy reviews the evidence for and against AF ablation in this complex condition from two different perspectives r...
L. di Biase, Carolyn S. P. Lam, Feng-Wei Zou et al.· Europace· 0 citations
Treatment with mitiperstat, intended to target the neutrophil–MPO inflammatory pathway, did not improve symptoms or exercise function in individuals with heart failure with preserved or mildly reduced ejection fraction.
Lars H. Lund, Carolyn S. P. Lam, P. E. Pizzato et al.· Nature Medicine· 1 citation
BACKGROUND
The HFpEF-ABA score is a simple diagnostic tool developed to estimate the probability of heart failure with preserved ejection fraction (HFpEF) using age, body mass index, and history of atrial fibrillation.
OBJECTIVES
This study aims to evaluate the HFpEF-ABA score in patients with confirmed heart failure...
R. Ono, K. Docherty, A. Henderson et al.· JACC. Heart failure· 0 citations
BACKGROUND
Heart failure (HF) is a common cardiovascular complication of diabetes. Early identification of unrecognized HF enables initiation of disease-modifying therapies. International diabetes and HF clinical practice guidelines are inconsistent with respect to recommendations for screening for HF in people with di...
D. Taylor-Sweet, M. Petrie, Gemma Mckinley et al.· Journal of the American Coll...· 1 citation
In this selected cohort of adults at increased CV risk, persistent CRP elevation was associated with higher risk of incident HF and all-cause mortality and may suggest the prognostic relevance of elevated CRP and warrant further study of inflammation in HF development.
M. Busti, L. Monzo, T. Rastogi et al.· International Journal of Car...· 1 citation
The improvements in cardiovascular risk factor exposure in the Asia–Pacific have been offset by population growth and ageing, and the metabolic-centric pattern in risk factors demands for strategies in tackling the region's high priority metabolic risk factor targets.
Nicholas W. S. Chew, Yi-Ming Chen, F. Cader et al.· The Lancet Regional Health -...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.